Kista Ovarium Jinak

01Pathophysiology

The majority of ovarian cysts in premenopausal women are functional cysts, meaning they arise directly from the normal ovulatory cycle rather than from neoplastic growth.

A follicular cyst forms when a dominant follicle fails to rupture and release its oocyte during ovulation. Instead of regressing, the follicle continues to enlarge under the influence of follicle-stimulating hormone (FSH) and accumulates fluid. These cysts are typically thin-walled, unilocular, and filled with clear serous fluid. They are almost always self-limiting and resolve within one to three menstrual cycles. This is why a vignette describing a simple, anechoic cyst under 5 cm in a young woman points toward observation rather than surgery.

A corpus luteum cyst develops after ovulation has occurred. The corpus luteum, which normally produces progesterone to support a potential pregnancy, fails to regress and instead fills with blood or fluid. Because the corpus luteum has a rich vascular supply, these cysts are more prone to hemorrhage than follicular cysts. A ruptured corpus luteum cyst classically presents with sudden, unilateral lower abdominal pain mid-cycle or in the luteal phase, and it is a common mimic of ectopic pregnancy. The key differentiator is a negative beta-hCG.

A mature cystic teratoma (dermoid cyst) is the most common benign ovarian neoplasm in reproductive-age women. It arises from totipotent germ cells and contains tissue from all three embryonic germ layers: ectoderm (skin, hair, sebaceous glands), mesoderm (fat, bone, cartilage, muscle), and endoderm (thyroid tissue, respiratory epithelium). This is why imaging may show fat, calcification, or even teeth within the cyst. The pathophysiology is not hormonal but developmental. Dermoid cysts grow slowly and rarely undergo malignant transformation (less than 1 to 2%, usually into squamous cell carcinoma, and almost exclusively in postmenopausal women). A feared complication is ovarian torsion, because the cyst's weight can cause the ovary to twist on its pedicle.

An endometrioma ("chocolate cyst") is formed when ectopic endometrial tissue implants on or within the ovary. During each menstrual cycle, this tissue undergoes hormonally driven proliferation and bleeding, but the blood has no outlet. Over time, the cyst fills with old, degraded blood products, giving it a characteristic thick, dark brown, tar-like content. This directly explains the "ground glass" or homogeneous low-level internal echoes seen on ultrasound. Endometriomas are a hallmark of Stage III or IV endometriosis and are strongly associated with chronic pelvic pain, dysmenorrhea, and infertility.

Serous cystadenomas are the most common benign epithelial ovarian neoplasms overall. They are lined by tubal-type (ciliated) epithelium and are typically unilocular, thin-walled, and filled with clear, watery fluid. Mucinous cystadenomas tend to be larger (sometimes exceeding 15 to 20 cm), multiloculated, and filled with thick, gelatinous mucin. Both are benign but require surgical excision because they do not resolve spontaneously, and mucinous variants carry a risk of pseudomyxoma peritonei if ruptured.

02Classification and Clinical Manifestation

03Diagnostic Workup

The first action in any reproductive-age woman who presents with pelvic pain or an adnexal mass is a urine or serum beta-hCG. This is non-negotiable on exams. You must exclude pregnancy before pursuing any further workup, because an ectopic pregnancy can present identically to a ruptured corpus luteum cyst and requires entirely different management.

Once pregnancy is excluded, transvaginal ultrasound is the best initial imaging test. It is highly sensitive for characterizing ovarian cysts and can often provide a confident diagnosis based on the cyst's morphology. A simple cyst (thin wall, anechoic interior, no solid components, no septations, posterior acoustic enhancement) in a premenopausal woman is overwhelmingly benign and can be observed. The more internal complexity you see (thick septations, solid nodules, papillary projections, irregular walls, internal blood flow on Doppler), the higher the suspicion for malignancy.

CA-125 is not a screening tool and is not useful in isolation in premenopausal women because it is elevated by many benign conditions including endometriosis, pelvic inflammatory disease, fibroids, and even menstruation. Its utility increases in postmenopausal women, where an elevated CA-125 combined with a complex-appearing cyst on ultrasound significantly raises the probability of ovarian cancer. The Risk of Malignancy Index (RMI), which integrates ultrasound morphology, CA-125 level, and menopausal status, is a validated tool for triaging patients to gynecologic oncology versus routine gynecologic surgery.

MRI is reserved for cases where ultrasound findings are equivocal. It excels at tissue characterization: fat saturation sequences can confirm dermoid cysts, and T1-weighted hyperintensity with T2 "shading" is characteristic of endometriomas. MRI is also used for surgical planning when the relationship of the cyst to surrounding structures needs clarification.

The most accurate (confirmatory) test is always histopathologic examination of the excised specimen. No imaging modality can definitively rule out malignancy; only tissue diagnosis can.

04Management and Treatment

The cornerstone principle is that most functional ovarian cysts in premenopausal women resolve on their own and do not require intervention. The "next best step" for a simple, small, asymptomatic cyst on a licensing exam is nearly always observation with repeat imaging. Jumping to surgery for a simple cyst in a young woman is a classic wrong answer.

Oral contraceptive pills are frequently tested. Students must understand that OCPs prevent formation of new functional cysts by suppressing ovulation (through inhibition of the hypothalamic-pituitary-ovarian axis and suppression of the LH surge). However, they do not shrink or resolve an already-formed cyst. A vignette asking "what is the best treatment for an existing 4 cm follicular cyst" where OCPs is an answer choice is a trap: the correct answer is observation, not OCPs.

For acute presentations, the critical branch point is hemodynamic stability. A hemodynamically stable patient with a suspected ruptured cyst receives IV fluids, pain control with NSAIDs, and serial monitoring of vital signs and hemoglobin. A hemodynamically unstable patient (tachycardia, hypotension, dropping hemoglobin, significant free fluid in the pelvis) requires emergent surgical intervention.

Ovarian torsion is a surgical emergency. The classic presentation is sudden onset of severe, colicky, unilateral pelvic pain often accompanied by nausea and vomiting in a woman with a known ovarian cyst (dermoid cysts are the most common benign tumor causing torsion). On exam, there is a tender adnexal mass. Doppler ultrasound may show absent blood flow, but normal Doppler does not rule out torsion because intermittent torsion and dual blood supply can preserve flow. The management is emergent laparoscopic detorsion. Ovarian salvage (untwisting without removal) is the preferred approach even if the ovary looks ischemic, because the ovary frequently recovers function.

For dermoid cysts, surgical removal is recommended regardless of symptoms because they do not regress, they may slowly enlarge, and they carry a meaningful risk of torsion. Ovarian cystectomy (removing the cyst while preserving the remaining ovarian tissue) is preferred over oophorectomy in women of reproductive age.

For endometriomas, management depends on symptoms and fertility goals. Medical therapy with combined hormonal contraceptives, progestins (medroxyprogesterone, norethindrone), or GnRH agonists (leuprolide) can suppress endometriotic tissue growth and provide symptom relief. However, these treatments are suppressive, not curative, and symptoms often return after discontinuation. Surgical excision is considered for endometriomas larger than 4 cm, for refractory symptoms, or when fertility is a priority, because large endometriomas can damage surrounding ovarian tissue and impair oocyte quality.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common way students lose points on benign ovarian cyst questions is by selecting surgery or OCPs as the initial management for a simple functional cyst in a premenopausal woman. The exam rewards you for recognizing that observation with repeat ultrasound is the appropriate first step. A simple, anechoic, thin-walled cyst under 5 to 7 cm in a young woman is overwhelmingly benign and will almost certainly resolve on its own. Surgery is reserved for cysts that persist beyond two to three menstrual cycles, enlarge on follow-up imaging, become symptomatic, or have worrisome morphologic features.

Another frequent trap involves OCPs. Many students believe that prescribing oral contraceptives will "treat" or shrink an existing ovarian cyst. This is incorrect. OCPs suppress future ovulation and prevent new cysts from forming, but they have no effect on the resolution of a cyst that is already present. The exam tests this distinction directly.

A third high-yield testing point is the differentiation between a ruptured corpus luteum cyst and an ectopic pregnancy. Both present with acute pelvic pain, an adnexal mass, and free fluid in the cul-de-sac. The discriminator is the beta-hCG result. If the vignette does not provide it, the next best step is to order it. Never skip this test.

Finally, students must recognize that the approach to an adnexal mass changes entirely based on menopausal status. In a premenopausal woman, a simple cyst is almost always benign and can be observed. In a postmenopausal woman, any new ovarian cyst (even a small, simple-appearing one) warrants a more cautious workup including CA-125 and close surveillance, because the baseline risk of ovarian malignancy is significantly higher and functional cysts should not be forming in the absence of ovulation. A complex cyst with solid components or elevated CA-125 in a postmenopausal woman should prompt referral to gynecologic oncology, not expectant management.

The core competency being tested is the ability to stratify risk based on patient age, imaging morphology, and tumor markers, and to apply the correct management algorithm (observation versus surgery versus oncology referral) at each decision point.